C12N 2501/148
Transforming growth factor alpha [tgf-a]
Official title: Transforming growth factor alpha [TGF-a]
C12N2501/148 (Transforming growth factor alpha [tgf-a]) appears on 84 US grants and 122 published applications in this corpus.
Search patents in C12N- Granted patents
- 84
- Published applications
- 122
- Assignees
- 75
- Inventors
- 193
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 1 | 0 |
| 2002 | 5 | 6 |
| 2003 | 4 | 8 |
| 2004 | 0 | 6 |
| 2005 | 0 | 5 |
| 2006 | 7 | 6 |
| 2007 | 5 | 1 |
| 2008 | 2 | 3 |
| 2009 | 3 | 7 |
| 2010 | 1 | 4 |
| 2011 | 0 | 5 |
| 2012 | 2 | 2 |
| 2013 | 3 | 4 |
| 2014 | 2 | 3 |
| 2015 | 4 | 5 |
| 2016 | 3 | 5 |
| 2017 | 5 | 4 |
| 2018 | 0 | 2 |
| 2019 | 3 | 3 |
| 2020 | 2 | 5 |
| 2021 | 1 | 5 |
| 2022 | 9 | 11 |
| 2023 | 1 | 8 |
| 2024 | 1 | 3 |
| 2025 | 6 | 5 |
| 2026 | 2 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Generating aorta-gonad-mesonephros-like hematopoietic cells from human pluripotent stem cells under a defined condition15 Sep 2026US 12,735,679 B2Purdue Research Foundation
- Biocompatible conditioned cell medium compositions and uses thereof16 Jun 2026US 12,655,384 B2Cellum Biomedical, Inc.
- Hepatocyte expansion methods16 Dec 2025US 12,497,596 B2Koninklijke Nederlandse Akademie van Wetenschappen
- Lyophilized compositions containing umbilical cord lining stem cells conditioned medium4 Nov 2025US 12,460,179 B2Restem LLC
- Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs16 Sep 2025US 12,415,989 B2Fate Therapeutics, Inc.
- Culture media and conditions for in vitro expansion and/or maturation of hepatocytes24 Sep 2026US 2026/0286311 A1Satellite Biosciences, Inc.
- Culture media and conditions for in vitro expansion and/or maturation of hepatocytes11 Jun 2026US 2026/0159813 A1Satellite Biosciences, Inc.
- Hepatocyte Expansion Methods14 May 2026US 2026/0132380 A1Koninklijke Nederlandse Akademie van Wetenschappen
- Gene correction induced neural stem cells using huntingtin gene-specific guide rna, and cell therapeutic agent using the same30 Apr 2026US 2026/0115318 A1Korea University Research and Business Foundation
- System and Method For Converting Adipose Derived Mesenchymal Stem Cells To Hematopoietic Stem/Progenitor Cells And Differentiating Into Blood Cells And Applications Of Same23 Apr 2026US 2026/0109947 A1Ul Cell Therapeutic Pte. Ltd
Most cited
By later US patents
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998
- In vitro growth and proliferation of multipotent neural stem cells and their progeny265US 5,851,832 ANeurospheres, Ltd. · 1998
- Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals223US 5,753,506 ACNS Stem Cell Technology, Inc. · 1998
- Neural transplantation using proliferated multipotent neural stem cells and their progeny176US 6,497,872 B1Neurospheres Holdings Ltd. · 2002
- Hepatocyte lineage cells derived from pluripotent stem cells175US 6,458,589 B1Geron Corporation · 2002